Literature DB >> 8506268

Tumor immunogenicity: how far can it be pushed?

R T Prehn1.   

Abstract

Mesh:

Year:  1993        PMID: 8506268      PMCID: PMC46503          DOI: 10.1073/pnas.90.10.4332

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Failure of immunosurveillance against chemically induced in situ tumors in mice.

Authors:  E J Andrews
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

3.  Effect of host immunity on the antigenic strength of primary tumors.

Authors:  G L Bartlett
Journal:  J Natl Cancer Inst       Date:  1972-08       Impact factor: 13.506

4.  Immunodepression and malignancy.

Authors:  O Stutman
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

5.  Immunostimulation of chemical oncogenesis in the mouse.

Authors:  R T Prehn
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

6.  Relationship of tumor immunogenicity to concentration of the oncogen.

Authors:  R T Prehn
Journal:  J Natl Cancer Inst       Date:  1975-07       Impact factor: 13.506

Review 7.  The autoimmune nature of cancer.

Authors:  R T Prehn; L M Prehn
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

8.  Influence of immune status of host on immunogenicity of tumors induced with two doses of methylcholanthrene.

Authors:  E M Lawler; R T Prehn
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

9.  Development of carcinogen-induced skin tumors in mice with varied states of immune capacity.

Authors:  H C Outzen
Journal:  Int J Cancer       Date:  1980-07-15       Impact factor: 7.396

10.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  3 in total

1.  Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.

Authors:  T Tsujiuchi; Y Sasaki; M Tsutsumi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2000-10

2.  Nano size effects of TiO2 nanotube array on the glioma cells behavior.

Authors:  He Yang; Xiaofei Qin; Ang Tian; Dongyong Zhang; Xiangxin Xue; Anhua Wu
Journal:  Int J Mol Sci       Date:  2012-12-21       Impact factor: 5.923

Review 3.  Tumor reductive therapies and antitumor immunity.

Authors:  Huiqin Guo; Kangla Tsung
Journal:  Oncotarget       Date:  2017-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.